On June 10, 2008, VIVUS, Inc. issued a press release titled “Qnexa Reduces Hemoglobin A1c by 1.2 Percent in 28 Weeks.” A copy of the press release is attached hereto as Exhibit 99.1.
The information in this Form 8-K and the exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference into any of the Registrant’s filings under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits.
|
Exhibit No. |
|
Description |
|
|
|
|
|
|
|
99.1 |
|
Press Release dated June 10, 2008 |
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
VIVUS, INC. |
|
|
|
|
|
|
By: |
/s/ Lee B. Perry |
|
|
|
Lee B. Perry Vice President and Chief Accounting Officer |
Date: June 10, 2008
EXHIBIT INDEX
|
Exhibit No. |
|
Description |
|
|
|
|
|
|
|
99.1 |
|
Press Release dated June 10, 2008 |
|